Get my own profile
Public access
View all36 articles
6 articles
available
not available
Based on funding mandates
Co-authors
- Mikhail SavitskiEMBLVerified email at embl.de
- Gerard DrewesCellzome/GlaxoSmithKline R&DVerified email at gsk.com
- Bernhard KusterProfessor for Proteomics and BioanalyticsVerified email at tum.de
- Isabelle BecherEMBL HeidelbergVerified email at embl.de
- Nico ZinnCellzome GmbH, a GSK companyVerified email at gsk.com
- Wolfgang HuberEMBL - European Molecular Biology LaboratoryVerified email at embl.org
- Nils KurzawaCellzome, a GSK companyVerified email at gsk.com
- Friedrich ReinhardVP Academic Partnerships, Evotec International GmbHVerified email at evotec.com
- Michael O. GlockerProteome Center RostockVerified email at med.uni-rostock.de
- Mathias WilhelmComputational Mass Spectrometry, Technical University of MunichVerified email at tum.de
- Hannes HahneOmicScouts GmbHVerified email at omicscouts.com
- Markus SchirleNovartis Biomedical ResearchVerified email at novartis.com
- Rab PrinjhaChief R&D Officer Curve TherapeuticsVerified email at Curvetx.com
- Yann AbrahamJohnson & JohnsonVerified email at its.jnj.com
- Hans-Juergen ThiesenProfessor of Immunology,University RostockVerified email at med.uni-rostock.de
- Dominic HelmProteomics Core Facility, DKFZVerified email at dkfz-heidelberg.de
- Par NordlundKarolinska InstitutetVerified email at ki.se
- Daniel Martinez MolinaCSO at Pelago Bioscience, SwedenVerified email at pelagobio.com
- Fiona PachlAstraZenecaVerified email at astrazeneca.com
- Arjen ScholtenPrincipal Scientist Analytical Development; Janssen Vaccines & PreventionVerified email at its.jnj.com